In-Vitro Diagnostics market is one of the most valued segment in the global healthcare industry. The global market of IVD is expected to reach USD XX million by 2022 from USD XX million in 2016, at a CAGR of XX%. IVD plays a major role in the early diagnosis and management of diseases. The medical devices and accessories in IVD are used to perform tests on samples, such as blood, urine and tissue from the human body to detect infection, diagnose a medical condition, prevent disease, and monitor drug therapies. Devices usually range from simple tests to sophisticated DNA technology including reagents, calibrators, control materials, kits, software, and related instruments.
This market is primarily driven by demand for personalized medicines. It is increasingly preferred for oncology related diseases. Other important factors are raising incidents of infectious diseases, emerging need for minimally invasive technologies and increasing point of care testing.
The growth of this market is restrained particularly due to complex reimbursement policies in developed and emerging markets. Increase in healthcare costs is also a predominant factor impeding growth of this market.
The IVD market has been segmented by techniques, applications, end users and geography. Techniques include Immunoassay, Clinical Chemistry, Microbiology, Hematology, Point of Care and others. Applications refer to diseases being used into such as diabetes, cancer, autoimmune diseases and others. Geographically, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America.
Some of the key players in this market include –
Abbott Laboratories Ltd, Roche Diagnostics, Danaher Corporation, Alere Incorporated, Bayer International AG, BioRad Laboratories, Johnson & Johnson, Becton Dickinson & Company, Biomerieux SA, Bristol-Myers Squibb Company, Siemens Healthcare AG, Thermo Fisher Scientific Inc and others
Market analysis for the market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers, restraints opportunities and challenges.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with company profiles of key players with the analysis of their current strategic interests and key financial information.
Identification and analysis of the macro and micro factors that affect the In-Vitro Diagnostics Market. Insights of the market in the regions that have the highest potential for growth and also identify the markets that are still untapped.